Attenuation of allergic airway inflammation in a murine model of asthma by Licochalcone A

References

• Galli SJ, Tsai M, Piliponsky AM. The development of allergic inflammation. Nature 2008;454:445–454
   PubMed Web of Science ®Google Scholar
• Tomkinson A, Cieslewicz G, Duez C, et al. Temporal association between airway hyperresponsiveness and airway eosinophilia in ovalbumin-sensitized mice. Am J Respir Crit Care Med 2001;63:721–730
   Google Scholar
• Lin Y, Yan H, Xiao Y, et al. Attenuation of antigen-induced airway hyperresponsiveness and inflammation in CXCR3 knockout mice. Respir Res 2011;12:123. doi: 10.1186/1465-9921-12-123
   PubMedGoogle Scholar
• Holgate ST, Polosa R. The mechanisms, diagnosis, and management of severe asthma in adults. Lancet 2006;368:780–793
   PubMed Web of Science ®Google Scholar
• Hatano T, Kagawa H, Yasuhara T, Okuda T. Two new flavonoids and other constituents in licorice root: their relative astringency and radical scavenging effects. Chem Pharm Bull 1988;36:2090–2097
   PubMed Web of Science ®Google Scholar
• Fu Y, Hsieh TC, Guo J, et al. Licochalcone-A, a novel flavonoid isolated from licorice root (Glycyrrhiza glabra), causes G2 and late-G1 arrests in androgen-independent PC-3 prostate cancer cells. Biochem Biophys Res Commun 2004;322:263–270
   PubMed Web of Science ®Google Scholar
• Rafi MM, Rosen RT, Vassil A, et al. Modulation of bcl-2 and cytotoxicity by licochalcone-A, a novel estrogenic flavonoid. Anticancer Res 2000;20:2653–2658
   PubMed Web of Science ®Google Scholar
• Funakoshi-Tago M, Tago K, Nishizawa C, et al. Licochalcone A is a potent inhibitor of TEL-Jak2-mediated transformation through the specific inhibition of Stat3 activation. Biochem Pharmacol 2008;1576:1681–1693
   Google Scholar
• Tsang F, Koh AH, Ting WL, et al. Effects of mitogen-activated protein kinase inhibitor PD 098059 on antigen challenge of guinea-pig airways in vitro. Br J Pharmacol 1998;25:61–68
   Google Scholar
• Chu X, Ci X, Wei M, et al. Licochalcone a inhibits lipopolysaccharide-induced inflammatory response in vitro and in vivo. J Agric Food Chem 2012;60:3947–3954
   PubMed Web of Science ®Google Scholar
• Bao Z, Lim S, Liao W, et al. Glycogen synthase kinase-3b inhibition attenuates asthma in mice. Am J Respir Crit Care Med 2007;176:431–438
   PubMed Web of Science ®Google Scholar
• Teran LM, Mochizuki M, Bartels J, et al. Th1- and Th2-type cytokines regulate the expression and production of eotaxin and RANTES by human lung fibroblasts. Am J Respir Cell Mol Biol 1999;20:777–786
   PubMed Web of Science ®Google Scholar
• Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Biotechnology 1992;24:145–149
   PubMedGoogle Scholar
• Hogan SP, Rosenberg HF, Moqbel R, et al. Eosinophils: biological properties and role in health and disease. Clin Exp Allergy 2008;38:709–750
   PubMed Web of Science ®Google Scholar
• Kelly M, Hwang JM, Kubes P. Modulating leukocyte recruitment in inflammation. J Allergy Clin Immunol 2007;120:3–10
   PubMed Web of Science ®Google Scholar
• Zhu Z, Zheng T, Homer RJ, et al. Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation. Science 2004;304:1678–1682
   PubMed Web of Science ®Google Scholar
• Iwashita H, Morita S, Sagiya Y, Nakanishi A. Role of eosinophil chemotactic factor by T lymphocytes on airway hyperresponsiveness in a murine model of allergic asthma. Am J Respir Cell Mol Biol 2006;35:103–109
   PubMed Web of Science ®Google Scholar
• Morcillo EJ, Cortijo J. Mucus and MUC in asthma. Curr Opin Curr Opin Pulm Med 2006;12:1–6
   PubMed Web of Science ®Google Scholar
• Kim DY, Park BS, Hong GU, et al. Anti-inflammatory effects of the R2 peptide, an inhibitor of transglutaminase 2, in a mouse model of allergic asthma, induced by ovalbumin. Br J Pharmacol 2011;162:210–225
   PubMedGoogle Scholar
• Lee JH, Lee JY, Kim TD, Kim CJ. Antiasthmatic action of dibenzylbutyrolactone lignans from fruits of Forsythia viridissima on asthmatic responses to ovalbumin challenge in conscious guinea-pigs. Phytother Res 2011;25:387–395
   PubMed Web of Science ®Google Scholar
• Allakhverdi Z, Allam M, Guimond A, et al. Multitargeted approach using antisense oligonucleotides for the treatment of asthma. Ann N Y Acad Sci 2006;1082:62–73
   PubMed Web of Science ®Google Scholar
• Elsner J, Escher SE, Forssmann U. Chemokine receptor antagonists: a novel therapeutic approach in allergic diseases. Allergy 2004;59:1243–1258
   PubMed Web of Science ®Google Scholar
• Fortin M, Ferrari N, Higgins ME, et al. Effects of antisense oligodeoxynucleotides targeting CCR3 on the airway response to antigen in rats. Oligonucleotides 2006;16:203–212
   PubMed Web of Science ®Google Scholar
• Sénéchal S, Fahy O, Gentina T, et al. CCR3-blocking antibody inhibits allergen-induced eosinophil recruitment in human skin xenografts from allergic patients. Lab Invest 2002;82:929–939
   PubMed Web of Science ®Google Scholar
• Corrigan CJ, Kay AB. T cells and eosinophils in the pathogenesis of asthma. Immunol Today 1992;13:501–507
   PubMedGoogle Scholar
• Brusselle G, Kips J, Joos G, et al. Allergen-induced airway inflammation and bronchial responsiveness in wild-type and interleukin-4-deficient mice. Am J Respir Cell Mol Biol 1995;12:254–259
   PubMed Web of Science ®Google Scholar
• Coyle AJ, Le Gros G, Bertrand C, et al. Interleukin-4 is required for the induction of lung Th2 mucosal immunity. Am J Respir Cell Mol Biol 1995;13:54–59
   PubMed Web of Science ®Google Scholar
• Kips JC, Brusselle GG, Joos GF, et al. Importance of interleukin-4 and interleukin-12 in allergen-induced airway changes in mice. Int Arch Allergy Immunol 1995;107:115–118
   PubMed Web of Science ®Google Scholar
• Sanderson CJ. Interleukin-5, eosinophils, and disease. Blood 1992;79:3101–3109
   PubMed Web of Science ®Google Scholar
• Simon D, Braathen LR, Simon HU. Eosinophils and atopic dermatitis. Allergy 2004;59:561–570
   PubMed Web of Science ®Google Scholar
• Anderson GP, Coyle AJ. TH2 and ‘TH2-like’ cells in allergy and asthma: pharmacological perspectives. Trends Pharmacol Sci 1994;15:324–332
   PubMed Web of Science ®Google Scholar
• Herrick CA, Bottomly K. To respond or not to respond: T cells in allergic asthma. Nat Rev Immunol 2003;3:405–412
   PubMed Web of Science ®Google Scholar
• Kips JC. Cytokines in asthma. Eur Respir J Suppl 2001;34:24s–33s
   PubMedGoogle Scholar
• Rosenberg HF, Phipps S, Foster PS. Eosinophil trafficking in allergy and asthma. J Allergy Clin Immunol 2007;119:1303–1310
   PubMed Web of Science ®Google Scholar
• Wills-Karp M, Luyimbazi J, Xu X, et al. Interleukin-13: central mediator of allergic asthma. Science 1998;282:2258–2261
   PubMed Web of Science ®Google Scholar
• Rogers DF. The airway goblet cell. Int J Biochem Cell Biol 2003;35:1–6
   PubMed Web of Science ®Google Scholar
• Justice JP, Crosby J, Borchers MT, et al. CD4(1) T cell-dependent airway mucus production occurs in response to IL-5 expression in lung. Am J Physiol Lung Cell Mol Physiol 2002;282:1066–1074
   Google Scholar
• Zhao J, Zhu H, Wong CH, et al. Increased lungkine and chitinase levels in allergic airway inflammation: a proteomics approach. Proteomics 2005;5:2799–2807
   PubMed Web of Science ®Google Scholar
• Chupp GL, Lee CG, Jarjour N, et al. A chitinase-like protein in the lung and circulation of patients with severe asthma. N Engl J Med 2007;357:2016–2027
   PubMed Web of Science ®Google Scholar
• Donnelly LE, Barnes PJ. Acidic mammalianchitinase-A potential target for asthma therapy. Trends Pharmacol Sci 2004;5:509–511
   Google Scholar
• Green RH, Brightling CE, McKenna S, et al. Asthma exacerbations and sputum eosinophil counts: a randomized controlled trial. Lancet 2002;360:1715–1721
   PubMed Web of Science ®Google Scholar
• Sont JK, Willems LN, Bel EH, et al. Clinical control and histopathologic outcome of asthma when using airway hyper-responsiveness as an additional guide to long-term treatment. Am J Respir Crit Care Med 1999;159:1043–1051
   PubMed Web of Science ®Google Scholar
• Duan W, Chan JH, Wong CH, et al. Anti-inflammatory effects of mitogenactivated protein kinase kinase inhibitor U0126 in an asthma mouse model. J Immunol 2004;172:7053–7059
   PubMed Web of Science ®Google Scholar